Teacher Retirement System of Texas Buys New Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Teacher Retirement System of Texas acquired a new position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 20,070 shares of the company's stock, valued at approximately $442,000.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Juncture Wealth Strategies LLC grew its position in Cellebrite DI by 0.8% during the fourth quarter. Juncture Wealth Strategies LLC now owns 60,003 shares of the company's stock worth $1,322,000 after buying an additional 505 shares in the last quarter. Strategic Advisors LLC increased its position in shares of Cellebrite DI by 3.4% in the fourth quarter. Strategic Advisors LLC now owns 29,082 shares of the company's stock worth $641,000 after purchasing an additional 950 shares during the period. Steward Partners Investment Advisory LLC raised its stake in Cellebrite DI by 12.1% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 13,590 shares of the company's stock valued at $299,000 after purchasing an additional 1,463 shares in the last quarter. Quarry LP bought a new stake in Cellebrite DI during the third quarter worth about $27,000. Finally, Tower View Wealth Management LLC grew its stake in Cellebrite DI by 1.3% during the fourth quarter. Tower View Wealth Management LLC now owns 132,307 shares of the company's stock worth $2,915,000 after buying an additional 1,660 shares in the last quarter. Institutional investors and hedge funds own 45.88% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Lake Street Capital upped their price target on shares of Cellebrite DI from $17.00 to $26.00 and gave the stock a "buy" rating in a report on Friday, February 14th. JPMorgan Chase & Co. upped their target price on Cellebrite DI from $24.00 to $28.00 and gave the stock an "overweight" rating in a research note on Tuesday, February 11th. Finally, Needham & Company LLC reissued a "buy" rating and set a $28.00 price target on shares of Cellebrite DI in a report on Wednesday. Seven equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company presently has an average rating of "Buy" and an average target price of $23.43.

Remove Ads

Cellebrite DI Price Performance

Shares of NASDAQ CLBT traded down $1.06 during mid-day trading on Friday, hitting $17.71. 1,386,431 shares of the stock traded hands, compared to its average volume of 1,397,574. The company has a market cap of $4.24 billion, a PE ratio of -12.74, a price-to-earnings-growth ratio of 4.27 and a beta of 1.44. Cellebrite DI Ltd. has a twelve month low of $10.25 and a twelve month high of $26.30. The firm has a 50 day simple moving average of $20.41 and a two-hundred day simple moving average of $19.95.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). Cellebrite DI had a positive return on equity of 58.70% and a negative net margin of 70.54%. On average, equities research analysts anticipate that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.